U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Drug Shortages
  5. 2015-2016 Influenza Season: Availability of Antivirals
  1. Drug Shortages

2015-2016 Influenza Season: Availability of Antivirals

  • Tamiflu (oseltamivir phosphate) Oral Suspension
    • No current shortage.
    • If there is difficulty locating commercial Tamiflu for Oral Suspension, FDA would like to remind healthcare professionals of the FDA-approved Instructions for the emergency compounding of an oral suspension from Tamiflu 75 mg capsules. This compounded suspension should not be used for convenience or when the FDA-approved Tamiflu for oral suspension is commercially available.  Please see information for healthcare professionals regarding compounding an oral suspension from Tamiflu 75 mg capsules at: Tamiflu: Emergency Compounding
  • Tamiflu (oseltamivir phosphate) 75 mg Capsules
    • No current shortage.
  • Tamiflu (oseltamivir phosphate) 45 mg Capsules
    • No current shortage.
    • Pediatric patients can be dosed correctly with the 30 mg and 45 mg capsules.
  • Tamiflu (oseltamivir phosphate) 30 mg Capsules
    • No current shortage.
    • Pediatric patients can be dosed correctly with the 30 mg and 45 mg capsules.
  • Relenza (zanamivir) Inhalation Powder
    • No current shortage.
Back to Top